fbpx

Insurance and AI

May 30, 2024
Read More

EXTRACAPSULAR EXTENSION RISK ASSESSMENT USING AN ARTIFICIAL INTELLIGENCE PROSTATE CANCER MAPPING ALGORITHM

May 21, 2024
Read More

Tumor Size Estimation Using AI-Generated Prostate Cancer Probability Maps

May 21, 2024
Read More

A NOVEL AI-DERIVED METRIC IDENTIFIES OPTIMAL CANDIDATES FOR FOCAL THERAPY OFPROSTATE CANCER AND ACCURATELY PREDICTS TREATMENT MARGIN EFFICACY

May 21, 2024
Read More

Artificial Intelligence-based Cancer Mapping to Aid in Prostate Cancer Therapy

May 21, 2024
Read More

The Importance of Precise Prostate Cancer Mapping

November 29, 2023
Read More

Avenda Health’s Revolutionary AI Mapping Tool for Prostate Cancer Achieves Landmark Category III CPT Code Designation

November 2, 2023
Read More

Avenda Health Featured on NBC News During President Biden’s AI Forum in SF

June 21, 2023
Read More

Stanford Research Study Provides Further Evidence for Avenda Health’s Personalized Prostate Cancer Mapping Using Machine Learning

June 21, 2023
Read More

Avenda Health’s Unfold AI™ Shown to More Precisely Predict Extraprostatic Extension Risk in Prostate Cancer Patients, Surpassing Conventional Methodology

April 27, 2023
Read More

Avenda Health Announces First Commercial Use of Unfold AI on Prostate Cancer Patients in the U.S.

April 25, 2023
Read More

Prostate Cancer Technology Startup, Avenda Health, Partnering with BioscienceLA to Establish New Life Sciences Innovation Hub in U.S.

April 19, 2023
Read More

A Novel AI – Derived Metric Identifies Favorable Candidates of Focal Therapy of Prostate Cancer and Accurately Predicts Treatment Margin Efficacy

March 13, 2023
Read More

Automatic Ablation Site Selection for Focal Therapy

March 13, 2023
Read More

Defining Prostate Cancer Focal Therapy Treatment Margins with a Machine Learning Model: Improvement Upon Hemi-Gland Ablation

March 13, 2023
Read More

Unfold AI Clinical Validation Efforts

March 13, 2023
Read More

First AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuest Receives FDA Clearance

December 13, 2022
Read More

Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance

December 11, 2022
Read More

Could an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?

December 7, 2022
Read More

Avenda Health Adds Tech Luminary to Board of Directors and Expands Leadership Team

August 26, 2022
Read More